Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron Variant
TUESDAY, Nov. 30, 2021 (HealthDay News) — Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant. The company noted that prior analyses suggest that its monoclonal antibody cocktail, and similar drugs, could lose effectiveness againstContinue Reading